Journal of Medical Physics
ORIGINAL ARTICLE
Year
: 2018  |  Volume : 43  |  Issue : 2  |  Page : 93--99

Validation of a software upgrade in a monte carlo treatment planning system by comparison of plans in different versions


P Mohandass1, D Khanna3, D Manigandan2, Narendra Kumar Bhalla3, Abhishek Puri3 
1 Department of Radiation Oncology, Fortis Cancer Institute, Fortis Hospital, Mohali, Punjab; Department of Physics, School of Engineering and Technology, Karunya Institute of Technology and Sciences, Coimbatore, Tamil Nadu, India
2 Department of Radiotherapy, Medanta The Medicity Hospital, Gurgaon, Haryana, India
3 Department of Radiation Oncology, Fortis Cancer Institute, Fortis Hospital, Mohali, Punjab, India

Correspondence Address:
Mr. P Mohandass
Department of Radiation Oncology, Fortis Hospital, Sector-62, Phase 8, SAS Nagar, Mohali - 160 062, Punjab
India

Purpose: Validation of a new software version of a Monte Carlo treatment planning system through comparing plans generated by two software versions in volumetric-modulated arc therapy (VMAT) for lung cancer. Materials and Methods: Three patients who were treated with 60 Gy/30 fractions in Elekta Synergy™ linear accelerator by VMAT technique with 2% statistical uncertainty (SU) were chosen for the study. Multiple VMAT plans were generated using two different software versions of Monaco treatment planning system TPS (V5.10.02 and V5.11). By keeping all other parameters constant, originally accepted plans were recalculated for the SUs of 0.5%, 1%, 2%, 3%, 4%, and 5%. For plan evaluation, the metrics compared were conformity Index (CI), homogeneity Index (HI), dose coverage to planning target volume (PTV), organ at risk (OAR) doses to spinal cord, pericardium, bilateral lungs-PTV, esophagus, liver, normal tissue integral dose (NTID), volumes receiving dose >5 and >10 Gy, calculation time (tCT), and gamma pass rates. Results: In both versions, CI and HI improved as the SU increased from 0.5% to 5%. No significant dose difference was observed in Dmean to PTV, bilateral lungs-PTV, pericardium, esophagus, liver, normal tissue volume receiving >5, and >10 Gy and NTID. It was observed that while the tCT and gamma pass rates decreased, the maximum dose to PTV increased as the SU increased. No other significant dose differences were observed between the two MC versions compared. Conclusion: For lung VMAT plans, in both versions, SU could be accepted up to 3% per plan with reduced tCT without compromising plan quality and deliverability by accepting variations in point dose and an inhomogeneous dose within the target. The plan quality of Monaco™V5.10.02 was similar to Monaco™TPS-V5.11 except for tCT.


How to cite this article:
Mohandass P, Khanna D, Manigandan D, Bhalla NK, Puri A. Validation of a software upgrade in a monte carlo treatment planning system by comparison of plans in different versions.J Med Phys 2018;43:93-99


How to cite this URL:
Mohandass P, Khanna D, Manigandan D, Bhalla NK, Puri A. Validation of a software upgrade in a monte carlo treatment planning system by comparison of plans in different versions. J Med Phys [serial online] 2018 [cited 2020 Jun 2 ];43:93-99
Available from: http://www.jmp.org.in/article.asp?issn=0971-6203;year=2018;volume=43;issue=2;spage=93;epage=99;aulast=Mohandass;type=0